drug

PF-08634404

1 story · latest Oct 30, 2026

Follow PF-08634404. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Code: SSGJ-707
Trials: 11 registered trials in coverage

Relationships

Developed by Pfizer

Timeline

UIC registers Phase 1 trial of Pfizer's elranatamab in plasmablastic lymphoma

Oct 30Weekly roundup, 11 itemsAstellas Pharma atirmociclib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.